caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1346276326

Benjamin LevyMD

Internal MedicineBaltimore, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
296
Unique beneficiaries
—
Total services
882
Distinct HCPCS
4
Medicare payment
$65K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,306 Internal Medicine providers in MD — above median (cohort median 884).
REFERRAL NETWORK

Where Benjamin Levy's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 7 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BETH ISRAEL MEDICAL CENTER886,261
Rosna Mirtcheva-Trocheva
Nuclear Medicine · New York, NY
15114
Theresa Shao
Internal Medicine · New York, NY
14204
HILFER, CAROL1470
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
BETH ISRAEL MEDICAL CENTER674,594
Stacey Weisman
Diagnostic Radiology · New York, NY
1991
Theresa Shao
Internal Medicine · New York, NY
18227
Rosna Mirtcheva-Trocheva
Nuclear Medicine · New York, NY
1255
Walter Choi
Radiation Oncology · Flushing, NY
122,742
Benjamin Bashist
Diagnostic Radiology · New York, NY
1139
Valerie Maccarrone
Diagnostic Radiology · Tucson, AZ
1165
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
73.9
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
178
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
9
Brand share
54.5%
Top prescribed drugs
Osimertinib Mesylate41 claims
Prochlorperazine Maleate23 claims
Dexamethasone23 claims
Levothyroxine Sodium18 claims
Alectinib Hcl18 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$53K
Payment records
41
By payment type
Consulting Fee$35K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$17K
Food and Beverage$1K
Travel and Lodging$405